Edition:
United Kingdom

Onxeo SA (C4X.PA)

C4X.PA on Paris Stock Exchange

0.97EUR
17 Jan 2019
Change (% chg)

-- (--)
Prev Close
€0.97
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
173,156
52-wk High
€2.00
52-wk Low
€0.84

Chart for

About

Onxeo SA, formerly Bioalliance Pharma SA, is a France-based biopharmaceutical company. In July 2014, the Company, as the continuing entity, merged with Topotarget AS creating Onxeo, a company dedicated to orphan oncology diseases. Onxeo aims at holding a portfolio of advanced programs targeting severe pathologies with unmet... (more)
No analyst recommendations are available for .

Overall

Beta: 0.73
Market Cap(Mil.): €88.20
Shares Outstanding(Mil.): 50.69
Dividend: --
Yield (%): --

Financials

  C4X.PA Industry Sector
P/E (TTM): -- 30.48 33.71
EPS (TTM): -0.45 -- --
ROI: -20.47 14.98 14.48
ROE: -24.16 16.31 15.99

Earnings vs. Estimates